Estudo do mundo real: Mounjaro da Eli Lilly supera Ozempic da Novo Nordisk na perda de peso

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Estudo do mundo real: Mounjaro da Eli Lilly supera Ozempic da Novo Nordisk na perda de peso

/jornal/2023/11/estudo-do-mundo-real-mounjaro-da-eli-lilly-supera-ozempic-da-novo-nordisk-na-perda-de-peso/

Lilly Drn (BOV:LILY34)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more Lilly Drn Charts.

Lilly Drn (BOV:LILY34)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more Lilly Drn Charts.

News

More News Articles

Impact Fusion (PK)

Ronn Motor (PK)

Kraig Biocraft Laborator... (QB)

ERHC Energy (CE)

Rennova Health (PK)

Net Savings Link (PK)

Digital Brand Media and ... (PK)

Voip Pal Com (QB)

SMC Entertainment (PK)

Northwest Biotherapeutics (QB)

NioCorp Developments

Fannie Mae (QB)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions